ARV Procurement and Distribution Project
Country of Operation
- Mission for Essential Drugs and Supplies (MEDS) KenyaNot-for-profit
Target income level
- Bottom 20%
- Lower-middle income (20-40%)
- Middle-income (40-60%)
- Higher middle-income (60-80%)
- High-income (80-100%)
SummaryThe ARV Procurement and Distribution project procures ART commodities for the Kenya PEPFAR program. Through Mission for Essential Drugs and Supplies (MEDS) Kenya, their core business is managing pharmaceutical supply chains in Kenya and the East & Central Africa region.
The project's role is to procure the life saving ART commodities, warehouse them taking into consideration each product's unique storage conditions as well as distribute the products to treatment sites in a timely and cost effective manner. MEDS is also charged with the responsibility of ensuring the quality of the pharmaceutical products during procurement, warehousing and distribution. Similarly, MEDS was contracted by USAID for 2 years (2006 & 2007) to train treatment sites on ART and non-ART health services, as well as in strategic information.
Key program components
The key activities include:
Procurement: MEDS procures ARVs and OI drugs both from overseas and local manufacturers. The products are approved by USFDA for ARVs and other stringent regulatory mechanism for OI drugs; they are also registered in-country by the Ministry of Health’s Pharmacy and Poisons Board. This ensures that the drugs meet international quality standards. MEDS also carries out Good Manufacturing Process (GMP) inspections both locally and overseas and undertakes random quality control testing of products on receipt in the warehouse as well as on return samples from the health facilities. MEDS has an on site WHO pre-qualified quality control laboratory that carries out this analysis.
Warehousing: The project has between 3-6 months of stock in the warehouse at any given time to ensure that the country has sufficient buffer stocks.
Distribution: MEDS has an elaborate and wide distribution network that is able to reach facilities in every corner of Kenya.
The project has achieved the following:
- More than 130,000 HIV/AIDS patients out of the 265,000 on ART receive their drugs from the MEDS supply chain mechanism. MEDS supply chain mechanism therefore takes care of about 50% of the current patients on ART.
- By June 2009, ART commodities valued at $ 95,703,829.72 had been paced with manufacturers and out of this; commodities valued at $ 85,683,970.56 had been received in MEDS warehouses representing a 89.53% draw down.
- Similarly, ART commodities valued at $86,873,825.44 had been distributed to treatment sites across the country. This figure includes ART commodities procured from other partners other than USAID.
- 397 treatment sites in the country rely on MEDS supply chain mechanism for their ART needs.
- In March 2009, MEDS quality control laboratory acquired WHO status making it the first faith based lab globally and the 4th in sub-Saharan Africa to acquire such status.
- 5th editions of Partners in Action fighting HIV/AIDS Newsletter have been published with the 6th edition being in progress.
- In January 2009, MEDS launched a bar-coding system ensures batch visibility, tracking, audit trail of all ART commodities. This will assist a great deal in the event of a drug recall.
- By August 2007 a total of 1718 heath care workers had been trained. 788 health care workers were trained on ART, 425 on non ART health services and 505 on strategic information.